A collage photo of Christos Hatzi and Alentis Therapeutics
May 4, 2024, 14:15
Christos Hatzis: I have joined Alentis Therapeutics as the Head of Translational Medicine
Christos Hatzis, Adjunct Associate Professor Of Medicine at Yale University School of Medicine, made the following post on LinkedIn:
“I am thrilled to share that I have joined Alentis Therapeutics as the Head of Translational Medicine.
I am truly impressed with the depth and quality of the clinical pipeline, and it would be a great honor to join the exceptionally talented team to help realize the full potential of Claudin-1 as a unique target in oncology and fibrosis.”
Source: Christos Hatzis/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 16, 2024, 12:06
Nov 16, 2024, 11:59
Nov 16, 2024, 11:50
Nov 16, 2024, 11:47
Nov 16, 2024, 11:40
Nov 16, 2024, 11:35
Nov 16, 2024, 11:32